Skip to main content

Advertisement

Table 2 Univariate analysis for biochemical relapse-free survival (bRFS) of patients with localized prostate cancer

From: Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer

Variate 5-year bRFS rate (%) P value
Age (years)
 ≤ 72 91.8 0.57
 > 72 93.6
Gleason score
 ≤ 6 96.7 < 0.01
 7 93.5
 ≥ 8 79.3
T stage
 T1–T2b 94.1 < 0.01
 T2c 60.0
 ≥ T3 69.3
Pretreatment PSA level (mg/dL)
 ≤ 10 93.5 < 0.01
 > 10 and ≤ 20 95.2
 > 20 80.2
D’Amico risk category
 Low risk 96.9 < 0.01
 Intermediate risk 93.3
 High risk 82.0
ADT
 No 96.6 < 0.01
 Yes 90.7